Baicalin induces ferroptosis in oral squamous cell carcinoma by suppressing the activity of FTH1
Authors:
- 21 February 2024
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 26 (2) , e3669
Abstract
Background: This study investigated the role of the ferroptosis‐related gene FTH1 in oral squamous cell carcinoma (OSCC) and evaluated the therapeutic potential of baicalin in OSCC cell treatment.Methods: A prognostic model was established by bioinformatic analysis, consisting of 12 ferroptosis related genes (FRGs), and FTH1 was selected as the most significantly up‐regulated FRGs. The clinical correlation of FTH1 in OSCC samples was evaluated by both immunohistochemical and bioinformatic characterizations. The effects of FTH1 on migration, invasion, epithelial–mesenchymal transition (EMT) and proliferation were determined by wound healing assays, transwell assays, western blotting and 5′‐ethynl 2′‐deoxyuridine proliferation assays, respectively. The effects of FTH1 on ferroptosis were tested via ferroptosis markers and Mito Tracker staining. In addition, the therapeutic effects of baicalin on OSCC cells were confirmed using EMT, migration, invasion, proliferation and ferroptosis assays.Results: The 12 FRGs were predictive of the prognosis for OSCC patients, and FTH1 expression was identified as significantly up‐regulated in OSCC samples, which was highly associated with survival, immune cell infiltration and drug sensitivity. Moreover, knocking down FTH1 inhibited cell proliferation, EMT and invasive phenotypes, but induced ferroptosis in OSCC cells (Cal27 and SCC25). Furthermore, baicalin directly suppressed expression of FTH1 in OSCC cells, and effectively promoted ferroptosis and inhibited the proliferation as well as EMT by directly targeting FTH1.Conclusions: This study has demonstrated that FTH1 is a therapeutic target for OSCC treatment, and has provided evidence that baicalin offers a promising alternative for OSCC treatment.Keywords
This publication has 33 references indexed in Scilit:
- Matrine disrupts Nrf2/GPX4 antioxidant system and promotes hepatocyte ferroptosisChemico-Biological Interactions, 2023
- Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosisBiomedicine & Pharmacotherapy, 2023
- Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axisPhytomedicine, 2023
- Ferroptosis Signature Shapes the Immune Profiles to Enhance the Response to Immune Checkpoint Inhibitors in Head and Neck CancerAdvanced Science, 2023
- CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosisDrug Resistance Updates, 2022
- Wogonin and its analogs for the prevention and treatment of cancer: A systematic reviewPhytotherapy Research, 2022
- Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axisBioactive Materials, 2021
- Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinomaInternational Immunopharmacology, 2021
- Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1Acta Pharmaceutica Sinica B, 2021
- Baicalin mediated regulation of key signaling pathways in cancerPharmacological Research, 2021